Losartan Pot/HCTZ 50/12.5 mg 90 Tabs NDC 72189-297-90 Packaged and Distributed By: Direct Rx Daws...

FDA Drug Recall #D-0894-2022 — Class II — May 11, 2022

Recall Summary

Recall Number D-0894-2022
Classification Class II — Moderate risk
Date Initiated May 11, 2022
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Direct Rx
Location Dawsonville, GA
Product Type Drugs
Quantity 6 bottles

Product Description

Losartan Pot/HCTZ 50/12.5 mg 90 Tabs NDC 72189-297-90 Packaged and Distributed By: Direct Rx Dawsonville, GA 30534 Mfg. For Macleods Pharma USA, Inc. Plainsboro, NJ 08540

Reason for Recall

CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits .

Distribution Pattern

FL

Lot / Code Information

Lots: 19NO2108 Exp. 1/31/25; 19NO2114 Exp. 1/31/25; 22NO2126 Exp. 1/31/25

Other Recalls from Direct Rx

Recall # Classification Product Date
D-0567-2025 Class II Duloxetine D/R, 20 mg, 30 Caps, 30-count bottle... Mar 7, 2025
D-0568-2025 Class II Duloxetine D/R, 30 mg, 30 Caps, RX Only, Packag... Mar 7, 2025
D-0364-2025 Class II CIPROFLOXACIN OPHTH SOLUTION, 0.3% 5mL bottle, ... Jan 31, 2025
D-0041-2025 Class II Ibuprofen 800mg, Generic for: Motrin, Each tabl... Aug 9, 2024
D-0508-2023 Class II Alprazolam C-IV, 1 mg, packaged in a) 30 Tabs p... Mar 22, 2023

Frequently Asked Questions

cGMP stands for Current Good Manufacturing Practice — the FDA's regulations governing drug manufacturing quality. A cGMP recall means the company failed to follow required manufacturing standards. This could involve inadequate testing, poor environmental controls, documentation failures, or process deviations. cGMP recalls do not always mean the product is directly harmful — in many cases, quality records are insufficient to confirm the product meets specifications. However, the FDA requires a recall because without proper documentation, product quality cannot be assured. These are often Class II or Class III recalls.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.